These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 33523597)

  • 1. ADR databases for on-site clinical use: Potentials of summary of products characteristics.
    Eiermann B; Rodriguez D; Cohen P; Gustafsson LL
    Basic Clin Pharmacol Toxicol; 2021 Apr; 128(4):557-567. PubMed ID: 33523597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Adverse Drug Reaction Database for Clinical Use - Potential of and Difficulties with the Summary of Product Characteristics.
    Eiermann B; Rodrigues D; Cohen P; Gustafsson LL
    Stud Health Technol Inform; 2022 May; 294():450-454. PubMed ID: 35612120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Information on adverse drug reactions-Proof of principle for a structured database that allows customization of drug information.
    Kusch MKP; Zien A; Hachenberg C; Haefeli WE; Seidling HM
    Int J Med Inform; 2020 Jan; 133():103970. PubMed ID: 31704490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E-pharmacovigilance: development and implementation of a computable knowledge base to identify adverse drug reactions.
    Neubert A; Dormann H; Prokosch HU; Bürkle T; Rascher W; Sojer R; Brune K; Criegee-Rieck M
    Br J Clin Pharmacol; 2013 Sep; 76 Suppl 1(Suppl 1):69-77. PubMed ID: 23586589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of safety issues with HIV drugs on the approval process of other drugs in the same class: an analysis of European Public Assessment Reports.
    Arnardottir AH; Haaijer-Ruskamp FM; Straus SM; de Graeff PA; Mol PG
    Drug Saf; 2011 Nov; 34(11):1101-14. PubMed ID: 21981437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation in adverse drug reactions listed in product information for antidepressants and anticonvulsants, between the USA and Europe: a comparison review of paired regulatory documents.
    Cornelius VR; Liu K; Peacock J; Sauzet O
    BMJ Open; 2016 Mar; 6(3):e010599. PubMed ID: 26996819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory Safety Learning Driven by the Mechanism of Action: The Case of TNF-α Inhibitors.
    Minnema LA; Giezen TJ; Hoekman J; Egberts TCG; Leufkens HGM; Gardarsdottir H
    Clin Pharmacol Ther; 2021 Jul; 110(1):123-131. PubMed ID: 33278830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ontological Organization and Bioinformatic Analysis of Adverse Drug Reactions From Package Inserts: Development and Usability Study.
    Li X; Lin X; Ren H; Guo J
    J Med Internet Res; 2020 Jul; 22(7):e20443. PubMed ID: 32706718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supervised signal detection for adverse drug reactions in medication dispensing data.
    Hoang T; Liu J; Roughead E; Pratt N; Li J
    Comput Methods Programs Biomed; 2018 Jul; 161():25-38. PubMed ID: 29852965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of serious adverse drug reactions using FDA-approved drug labeling and MedDRA.
    Wu L; Ingle T; Liu Z; Zhao-Wong A; Harris S; Thakkar S; Zhou G; Yang J; Xu J; Mehta D; Ge W; Tong W; Fang H
    BMC Bioinformatics; 2019 Mar; 20(Suppl 2):97. PubMed ID: 30871458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The contribution of Ghanaian patients to the reporting of adverse drug reactions: a quantitative and qualitative study.
    Jacobs TG; Hilda Ampadu H; Hoekman J; Dodoo ANO; Mantel-Teeuwisse AK
    BMC Public Health; 2018 Dec; 18(1):1384. PubMed ID: 30563498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse Drug Reactions from Real-World Data in Inflammatory Bowel Disease Patients in the IBDREAM Registry.
    Giraud EL; Thomas PWA; van Lint JA; van Puijenbroek EP; Römkens TEH; West RL; Russel MGVM; Jansen JM; Jessurun NT; Hoentjen F;
    Drug Saf; 2021 May; 44(5):581-588. PubMed ID: 33538994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Three Different Data Sources of Adverse Drug Reactions Using Adverse Drug Reaction Data of Fluorouracil for Gastric Cancer as an Example.
    Niu R; Chen Y; Xiang Y; Liu Y; Guo J; Feng B
    Biol Pharm Bull; 2020; 43(10):1476-1480. PubMed ID: 32999157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knowledge creation about ADRs--turning the perspective from the rear mirror to the projector?
    Aagaard L; Soendergaard B; Stenver DI; Hansen EH
    Br J Clin Pharmacol; 2008 Mar; 65(3):364-76. PubMed ID: 17961195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complementing the US Food and Drug Administration Adverse Event Reporting System With Adverse Drug Reaction Reporting From Social Media: Comparative Analysis.
    Zhou Z; Hultgren KE
    JMIR Public Health Surveill; 2020 Sep; 6(3):e19266. PubMed ID: 32996889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of information letters on the reporting rate of adverse drug reactions and the quality of the reports: a randomized controlled study.
    Johansson ML; Hägg S; Wallerstedt SM
    BMC Clin Pharmacol; 2011 Sep; 11():14. PubMed ID: 21899766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient Reporting of Adverse Drug Reactions (ADRs): Survey of Public Awareness and Predictors of Confidence to Report.
    Hariraj V; Aziz Z
    Ther Innov Regul Sci; 2018 Nov; 52(6):757-763. PubMed ID: 29714567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comprehensive intervention for adverse drug reactions identification and reporting in a Pediatric Emergency Department.
    Morales Ríos O; Jasso Gutiérrez L; Talavera JO; Téllez-Rojo MM; Olivar López V; Garduño Espinosa J; Muñoz Hernández O
    Int J Clin Pharm; 2016 Feb; 38(1):80-7. PubMed ID: 26499501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dataset of 200 structured product labels annotated for adverse drug reactions.
    Demner-Fushman D; Shooshan SE; Rodriguez L; Aronson AR; Lang F; Rogers W; Roberts K; Tonning J
    Sci Data; 2018 Jan; 5():180001. PubMed ID: 29381145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.